Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
"Corcel is a research client of Align Research. Align Research holds an interest in the shares of CRCL."
Thanks Jimzi, remind us where that came from and when please.
Current pause in sp growth is only a problem for traders / people looking for quick buck. If you're an investor no problem. It's a pause. ORPH has masses going for it on all fronts and value of holdings by year-end will be considerably higher than now. And there may be 1-off bonuses in-year too.
i should think he's waiting til invesco complete whatever they're up to. no point putting news out if their actions are just going to undermine it.
imho its someone who has access to the warrants selling a few of current holding to buy his / her equivalent # warrants at lower price. always happens. not a problem as the sells get mopped up and strengthen this as a new support.
as we all know, CNR is hugely undervalued at current levels anyway and if you take a longer term view, ie not a trader, you'll do very well from here during this year.
GLA
moving in right direction - up to over $25
RR - ah yes, have read it more carefully now. thanks. nonetheless, excellent news that this is underway - for ORPH as it demonstrates our industry-leading capabilities and involvement in development of 2nd generation vaccine, codagenix as it is an important milestone in a very important product development, and the world (!) - if it works it could be a gamechanger in the covid battle.
Is this a world first as far as we know?
It's a US development being trialled in the UK. Anyone know if it will have required approval by the NHS Health Research Authority's Research Ethics Committee? If yes, and that approval is in the bag, that is huge news. Opens the door for similar human challenge trials for 2nd generation vaccines.
Great news ORPH
anyone got any idea who the main holders of these are likely to be i.e. which fundraise do they relate to and who were the main participants. If Randy was in there, and if theories about his past behaviour are correct, then he may sell some of his remaining holding (if he still has any) and replace with warrants at a nice discount.
I'm a long term investor here and am hugely excited about the potential for affimers to change cancer treatment for good.
I try to keep up with the company's covid work but it is difficult to follow where it has got to, especially with shall we say less than revealing RNSs from the company now over an extended period, and reading this bb which is a forum for such conflicting views.
The company has been working on its covid plays and in partnership with numerous other companies for several months now. I don't understand why we still don't know if we have a working self-administered, rapid-reporting LFT, which meets specified necessary S&S, which can be manufactured in huge quantities.
This seems to me a simple and fundamental question, and the answer is so important, for investors yes, but much more so for our nation.
Munchbox - I've got my mental hat on
Bigdog - wow you must be clever and rich. Thanks so much for sharing
threeturn - perhaps you should read them a bit more carefully if you're really considering investing
VTM article is very good and yet barely scratches the surface of all the things bubbling just underneath which we're expecting will come to fruition over coming days, weeks and months. Great time to he invested here with so much promise for '21.
Interestingly ORPH is one of finnCap's top tips for this year - they issued a 60 page report yesterday titled '12 for 21 - Investment ideas for 2021'. Of course oiks like us can't access it as 'content is only available within our institutional and professional offerings'
Very encouraging to be in there though, even though today's research note seems to have missed so much of the good stuff!
GLA
Ah, a fellow Wonder-person! Welcome. I think you've made a very good decision! Good luck with your investment.
they're coming back. There's been some excellent posting by knowledgeable investors over this weekend, esp. about AVCT's cancer work. Thanks to all of you. Heads down now as the morons launch for another week's work.
Bazzao - thanks, I'm already in 2 of them and have high hopes ...
V helpful, thanks
Leewill - thanks for that re TMAC. Agreed, the 2019 results were brilliant. I think there was an aim to move towards human trials in 2020. Are you aware of progress on that?
Haven't heard of elric the lemming before, but he's bang on the money with numerous good reasons for ORPH optimism.
Don't forget we're technically still an explorer - unless we get taken over there's drilling to be done to get up to 5m oz +. We've already got a good idea where to look - I recall MC being very bullish about numerous targets once drilling gets going again.